GlassScriptPhysician profile
Joanna E Molina Razavi
NPI 1336303866
$25,654.73
in general payments reported to CMS, 2019-2025
33 companies · $757 in 2025
The $757 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,212 · 2020: $398 · 2021: $1,341 · 2022: $7,276 · 2023: $6,749 · 2024: $3,922 · 2025: $757.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,184 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,038 · Consulting Fee: $1,800 · Travel and Lodging: $406.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,184.46 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,037.50 |
| Consulting Fee | $1,800.00 |
| Travel and Lodging | $406.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $10,309.50 | 2019-2025 | Ensite Precision, Aveir, Gallant |
| Impulse Dynamics (USA) INC. | $3,827.18 | 2022-2024 | Optimizer, Optimizer |
| Biosense Webster, INC. | $3,749.86 | 2019-2025 | Carto 3 |
| Medtronic, INC. | $3,339.71 | 2021-2025 | Na, Corevalve Evolut R |
| Medtronic Vascular, INC. | $1,455.53 | 2019 | |
| Pfizer INC. | $466.79 | 2019-2024 | |
| Amgen INC. | $302.07 | 2019-2025 | Repatha, Repatha |
| Boston Scientific Corporation | $266.95 | 2019-2025 | Farapulse, Watchman Access System, Lux-Dx Insertable Cardiac Monitor |
| E.R. Squibb & Sons, L.L.C. | $242.61 | 2020-2025 | Eliquis, Camzyos |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $237.54 | 2019-2023 | Lifevest |
| Astellas Pharma US INC | $153.70 | 2019-2020 | |
| Biotronik INC. | $146.08 | 2019-2020 | |
| Abiomed | $138.88 | 2019 | |
| Bolton Medical INC | $133.89 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $109.26 | 2021-2024 | Uptravi, Opsumit |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $90.76 | 2021-2024 | Xarelto |
| Irhythm Technologies, INC. | $83.86 | 2023-2024 | Zio Xt Patch, Zio Monitor |
| Novartis Pharmaceuticals Corporation | $70.42 | 2022-2025 | |
| Itamar Medical INC | $62.93 | 2022-2023 | Watchpatone |
| Sanofi-Aventis U.S. LLC | $61.79 | 2022-2023 | |
| Astrazeneca Pharmaceuticals LP | $56.86 | 2019-2024 | Wainua, Farxiga |
| Triad Life Sciences INC. | $44.64 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $41.93 | 2024-2025 | Jardiance |
| Bardy Diagnostics, INC. | $40.00 | 2019-2021 | |
| W. L. Gore & Associates, INC. | $37.72 | 2020-2021 | |
| Chiesi USA, INC. | $33.15 | 2019-2020 | |
| Cvrx, INC. | $28.80 | 2024 | Barostim Neo System |
| Novo Nordisk INC | $24.71 | 2024 | |
| Baxter Healthcare | $23.99 | 2025 | Hillrom - Cardiac Ambulatory Monitor |
| Kestra Medical Technology Services, INC. | $22.99 | 2025 | Assure Wcd |
| Circa Scientific, INC. | $20.34 | 2025 | |
| Kiniksa Pharmaceuticals, LTD. | $18.68 | 2023 | Arcalyst |
| Elutia, INC. | $11.61 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joanna Molina Razavi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.